Kinaxis (TSE:KXS – Free Report) had its price target upped by Stifel Nicolaus from C$200.00 to C$225.00 in a research report report published on Thursday,BayStreet reports. They currently have a buy rating on the stock.
Several other equities analysts have also issued reports on KXS. Royal Bank Of Canada set a C$210.00 price target on shares of Kinaxis and gave the stock an “outperform” rating in a report on Wednesday, August 26th. National Bank Financial upped their price target on Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. RBC Dominion Securities set a C$210.00 price objective on Kinaxis and gave the company an “outperform” rating in a report on Friday, October 23rd. Finally, BMO Capital Markets raised their price objective on Kinaxis from C$195.00 to C$200.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating. According to MarketBeat.com, Kinaxis currently has an average rating of “Buy” and an average target price of C$206.67.
View Our Latest Analysis on KXS
Kinaxis Stock Performance
KXS stock opened at C$194.18 on Thursday. Kinaxis has a one year low of C$117.22 and a one year high of C$201.57. The firm has a market cap of C$5.28 billion, a price-to-earnings ratio of 63.46, a PEG ratio of 3.60 and a beta of 0.58. The company has a debt-to-equity ratio of 11.14, a quick ratio of 2.29 and a current ratio of 1.88. The firm has a 50-day simple moving average of C$180.55 and a two-hundred day simple moving average of C$155.72.
Kinaxis (TSE:KXS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C$1.71 earnings per share (EPS) for the quarter. The firm had revenue of C$225.60 million for the quarter. Kinaxis had a net margin of 14.40% and a return on equity of 20.88%. On average, equities analysts forecast that Kinaxis will post 4.25 EPS for the current fiscal year.
Insider Buying and Selling at Kinaxis
In other news, insider James Alexander Hollingworth sold 2,150 shares of the company’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of C$178.94, for a total transaction of C$384,721.00. Following the transaction, the insider owned 4,772 shares in the company, valued at C$853,901.68. This represents a 31.06% decrease in their ownership of the stock. Also, insider Andrew William Robert Bell sold 3,000 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of C$179.48, for a total transaction of C$538,440.00. Following the completion of the transaction, the insider directly owned 1,455 shares of the company’s stock, valued at C$261,143.40. The trade was a 67.34% decrease in their ownership of the stock. In the last three months, insiders have sold 33,730 shares of company stock valued at $5,877,368. Insiders own 1.20% of the company’s stock.
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Recommended Stories
- Five stocks we like better than Kinaxis
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
